Trials / Unknown

UnknownNCT02003001

Botulinum Toxin Injection to Prevent Ventricular Arrhythmias

Endomyocardial Botulinum Toxin Injection Can Prevent Ventricular Arrhythmias: Pilot Study

Status: Unknown
Phase: Phase 1
Study type: Interventional
Enrollment: 30 (estimated)

Sponsor: Meshalkin Research Institute of Pathology of Circulation · Network
Sex: All
Age: 18 Years – 70 Years
Healthy volunteers: Not accepted

Summary

The aim of this prospective non-randomized study was to assess the efficacy and safety of endomyocardial botulinum toxin injection in left ventricle for preventing ventricular arrhythmias.

Conditions

Symptomatic Ventricular Asystolia
Ventricular Tachycardia

Interventions

Type	Name	Description
DRUG	Botulinum Toxin

Timeline

Start date: 2013-06-01
Primary completion: 2016-03-01
Completion: 2016-12-01
First posted: 2013-12-06
Last updated: 2015-09-25

Locations

1 site across 1 country: Russia

Source: ClinicalTrials.gov record NCT02003001. Inclusion in this directory is not an endorsement.